Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 37Carcinoma, Non-Small-Cell Lung 28Glioblastoma 24Brain Neoplasms 23Esophageal Neoplasms 20Rectal Neoplasms 19Stomach Neoplasms 17Glioma 17Lung Neoplasms 16Colorectal Neoplasms 16Astrocytoma 14Pancreatic Neoplasms 12Central Nervous System Neoplasms 12Squamous Cell Carcinoma of Head and Neck 10Neoplasm Metastasis 10Head and Neck Neoplasms 10Gliosarcoma 10Sarcoma 9Oligodendroglioma 9Recurrence 8Neoplasms 8Adenocarcinoma Of Esophagus 8Esophageal Squamous Cell Carcinoma 7Uterine Cervical Neoplasms 6Ovarian Neoplasms 6Colonic Neoplasms 6Pilonidal Sinus 5Melanoma 5Carcinoma, Ovarian Epithelial 5Adenocarcinoma of Lung 5

Interventions

Irinotecan 13Cyclophosphamide 11Vincristine 10Filgrastim 10Radiotherapy 9Ifosfamide 9Doxorubicin 9Dactinomycin 7Melphalan 6Granulocyte Colony-Stimulating Factor 6Etoposide 6cixutumumab 5Sirolimus 5Peripheral Blood Stem Cell Transplantation 5pegfilgrastim 4Topotecan 4Temozolomide 4Radiation 4Gemcitabine 4Busulfan 4temsirolimus 3sargramostim 3Granulocyte-Macrophage Colony-Stimulating Factor 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3trioctyl phosphine oxide 2regorafenib 2olaparib 2etoposide phosphate 2eribulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Rhabdomyosarcoma × Surgical Procedures, Operative × Clear all
NCT00075582 2021-11-19

Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Completed
390 enrolled 14 charts
Sarcoma

Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡